ES2226326T3 - Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos. - Google Patents

Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos.

Info

Publication number
ES2226326T3
ES2226326T3 ES99811135T ES99811135T ES2226326T3 ES 2226326 T3 ES2226326 T3 ES 2226326T3 ES 99811135 T ES99811135 T ES 99811135T ES 99811135 T ES99811135 T ES 99811135T ES 2226326 T3 ES2226326 T3 ES 2226326T3
Authority
ES
Spain
Prior art keywords
human growth
growth hormone
use according
hgh
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99811135T
Other languages
English (en)
Spanish (es)
Inventor
Scott Chappel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Research Systems ARS Holding NV
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of ES2226326T3 publication Critical patent/ES2226326T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES99811135T 1998-12-17 1999-12-10 Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos. Expired - Lifetime ES2226326T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11266898P 1998-12-17 1998-12-17
US112668P 1998-12-17

Publications (1)

Publication Number Publication Date
ES2226326T3 true ES2226326T3 (es) 2005-03-16

Family

ID=22345222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99811135T Expired - Lifetime ES2226326T3 (es) 1998-12-17 1999-12-10 Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos.

Country Status (9)

Country Link
US (1) US6348444B1 (https=)
EP (1) EP1016414B1 (https=)
JP (1) JP2000178203A (https=)
AT (1) ATE275418T1 (https=)
DE (1) DE69919969T2 (https=)
DK (1) DK1016414T3 (https=)
ES (1) ES2226326T3 (https=)
PT (1) PT1016414E (https=)
SI (1) SI1016414T1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1016413A1 (en) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
EP2327724A3 (en) * 2004-02-02 2011-07-27 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
CA2576030A1 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5199942A (en) 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
WO1993000109A1 (en) * 1991-06-28 1993-01-07 Genentech, Inc. Method of stimulating immune response using growth hormone
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
DE69430059T2 (de) 1993-06-15 2002-11-14 British Biotech Pharmaceuticals Ltd., Cowley Freisetzung und Mobilisierung hämatopoietischer Zellen
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤

Also Published As

Publication number Publication date
DE69919969D1 (de) 2004-10-14
US6348444B1 (en) 2002-02-19
EP1016414A2 (en) 2000-07-05
PT1016414E (pt) 2004-12-31
EP1016414B1 (en) 2004-09-08
JP2000178203A (ja) 2000-06-27
SI1016414T1 (en) 2005-02-28
DE69919969T2 (de) 2005-09-29
EP1016414A3 (en) 2002-07-31
ATE275418T1 (de) 2004-09-15
DK1016414T3 (da) 2005-01-17

Similar Documents

Publication Publication Date Title
EP0904099B1 (en) Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
ES2535605T5 (es) Utilización de lipasa ácida lisosomal para el tratamiento de la deficiencia en lipasa ácida lisosomal en pacientes
ES2330193T3 (es) Hormona de crecimiento humano para estimular la movilizacion de celulas madre hematopoyeticas pluripotentes.
ES3036897T3 (en) Plasminogen for use in treating parkinson's and alzheimer's disease
EA007967B1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
EA011390B1 (ru) Мутантные белки (мутеины) фактора роста фибробластов 21
EP4729548A2 (en) Materials and methods for treating friedrich s ataxia
JP2010523501A (ja) Ｇｈｒｈ分子の医薬製剤
AU699346B2 (en) A pharmaceutical formulation comprising a growth hormone and valine
KR20080038391A (ko) 페그화 성장 호르몬의 액체 제제
ES2226326T3 (es) Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos.
ES2383994T3 (es) Formulación líquida de hormona del crecimiento
JP3697460B2 (ja) Ｈｇｆ含有製剤
ES2275359T3 (es) Uso de hormona de crecimiento humana para incrementar el numero de celulas cd34+circulantes, destinadas a regenerar los sistemas hematopoyetico e inmunologico despues de terapias mieloablativas o antiblasticas, por transplante, reinfusion o injerto.
EP1043027A1 (en) Treatment of multiple sclerosis with a combination of Interferon and Growth hormone
KR20080041661A (ko) 생체적합성 폴리머와 컨쥬게이트된 인간 성장 호르몬
AU4329596A (en) A stabilized pharmaceutical formulation comprising a growth hormone and x-lys
AU6353396A (en) A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue
JP3904268B2 (ja) Ｈｇｆ医薬製剤
JP2001522814A (ja) 増大されたｉｇｆ−ｉ溶解性を提供する組成物
Cerecetto Therapeutic Proteins
MXPA01006681A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells